AI-generated summary
The authors compared changes in three-dimensional macular shape over 12 months in 50 myopic children given either repeated low-level red-light therapy or 0.01% atropine eye drops. They report greater macular flattening in the red-light group across all regions, most pronounced centrally. The authors note that underlying mechanisms and the independent role of myopia progression require further study.
- Participants
- 50
- Who or what was studied
- Myopic children aged 7-15 years
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract describes a secondary analysis of a randomized trial with a small sample, and the mechanisms and the independent contribution of myopic progression remain unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on iovs.arvojournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Randomized controlled trial, Red light therapy, Myopia, Confidence interval, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.